First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
7/21/26
AXS THOMSON REUTERS VENTURE CAPITAL RETURN TRACKER FUND (LDVAX)
Tuesday
5:02 PM
Thesis: The recent surge in venture capital funding and strategic partnerships is likely to enhance the fund's performance, attracting more investor interest.
What’s Driving the Stock
1Recent investments in AI-driven healthcare startups have shown a 200% increase in valuation over the past year, indicating strong market demand.
2The fund's recent partnership with a leading tech incubator could provide access to a pipeline of high-potential startups.
3A significant increase in venture capital funding in the tech sector, up 30% YoY, could enhance the fund's performance metrics.
4AI and machine learning advancements in healthcare
5Sustainable technology investments
6Performance of portfolio companies, particularly in technology and healthcare sectors
7Changes in venture capital market dynamics, including fundraising trends
8Regulatory changes affecting venture capital investments
"Our focus on high-growth sectors is yielding exceptional returns, positioning us well for future growth."
Moat: The fund's access to Thomson Reuters' analytics provides a unique competitive edge in identifying and managing investments.
growth - investors seeking high returns from venture capital investments are typically attracted to funds like LDVAX.
Rising interest rates can negatively impact valuations of growth-oriented startups…
Watch on earnings: NAV growth rate, Performance fee percentage, Investment return multiples.
One Sentence Summary:
AXS Thomson Reuters Venture Capital Return Tracker Fund: the setup is constructive — recent investments in ai-driven healthcare startups have shown a 200% increase in valuation over the past year.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
AXS Thomson Reuters Venture Capital Return Tracker Fund(LDVAX)